The Russian company NtechLab (a Rostec partner) has developed products for detecting brain tumors and early signs of Alzheimer's disease using CT scans (computed tomography). The technological solutions are in a high degree of readiness, according to the state corporation's press service.
Previously, the company entered the medical technology market with the release of the NtechMed CT Brain stroke diagnosis product. It is used by doctors in Moscow clinics.
NtechLab signed 450 new contracts in 2024 and increased revenue to 1.7 billion rubles — a record figure.
Over the past 7 years, NtechLab's revenue has increased 18-fold. At the same time, 70% of revenue comes from Russian customers, and about 25% from foreign customers.
The company has transformed from a startup into a leader in the artificial intelligence (AI) market. It supplies solutions for "smart cities" abroad, including video analytics, road condition monitoring, and waste removal systems.
Read also on the topic:
A neural network for detecting brain hematomas on CT scans has been developed in St. Petersburg
AI helped doctors in Moscow make 14 million preliminary diagnoses
Russian scientists have created a neural network to improve the diagnosis and removal of tumors
